data_1e3t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e3t _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.038 0.447 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.483 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 1.2 p -137.63 -101.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 111.102 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 31' ' ' VAL 0.253 0.3 OUTLIER -175.23 36.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 117.964 -1.494 . . . . 0.0 111.629 -177.674 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -139.52 -176.3 4.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.954 -1.091 . . . . 0.0 110.285 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' N ' ' HD3' ' A' ' 32' ' ' LYS . . . -156.59 -77.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.47 142.55 28.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -124.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.283 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -52.58 -37.17 57.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 0.0 109.446 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -44.61 -27.6 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 108.727 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 36' ' ' ALA . 14.2 t70 -77.95 -37.13 48.22 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 36' ' ' ALA . . . -48.46 -48.29 37.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.325 -0.86 . . . . 0.0 109.647 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB1' ' CG ' ' A' ' 202' ' ' MET . . . -38.05 -32.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.73 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 45' ' ' ASN . 1.9 m-85 -85.07 -55.34 4.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.286 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.663 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -73.49 -12.6 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.258 -0.902 . . . . 0.0 110.332 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.593 ' CB ' HD13 ' A' ' 198' ' ' ILE . 2.3 mtt -114.87 -72.69 0.68 Allowed 'General case' 0 C--N 1.284 -2.276 0 O-C-N 121.259 -0.901 . . . . 0.0 111.356 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.26 12.13 3.11 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 41' ' ' PHE . 11.4 t30 -167.23 46.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.897 -1.127 . . . . 0.0 110.62 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . -132.13 90.18 2.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -19.57 -45.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -146.75 115.96 6.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.138 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.75 ' HB ' ' CZ ' ' A' ' 126' ' ' PHE . 1.8 t -135.69 -157.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.431 0 CA-C-O 122.011 0.91 . . . . 0.0 109.355 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.562 ' CG2' ' HB2' ' A' ' 81' ' ' SER . 0.0 OUTLIER -162.35 103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.661 -0.649 . . . . 0.0 109.878 179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.64 ' N ' ' CE1' ' A' ' 126' ' ' PHE . 1.2 tp -63.27 110.07 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' CG1' ' HA ' ' A' ' 127' ' ' VAL . 2.0 m -101.58 96.28 6.16 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 117.694 -1.602 . . . . 0.0 109.074 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' CA ' ' HE3' ' A' ' 57' ' ' MET . 53.6 Cg_endo -66.91 106.88 1.21 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 110.527 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 130' ' ' ALA . . . -96.78 -143.91 15.95 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.669 ' CD2' H52A ' A' ' 755' ' ' NAP . 0.2 OUTLIER -77.39 -45.59 25.44 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.309 -1.112 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 60' ' ' ALA . . . -67.07 -62.74 4.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.254 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.587 ' HE3' ' CA ' ' A' ' 53' ' ' PRO 0.287 0.8 OUTLIER -10.66 -76.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.759 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . . . -72.16 -32.34 66.78 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.659 0.742 . . . . 0.0 111.004 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -102.41 24.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 122.426 1.108 . . . . 0.0 108.669 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -122.21 -41.95 2.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.932 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 155.03 -27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' LEU . . . -46.22 -47.53 17.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' CB ' ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -31.98 -56.23 0.3 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.544 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -97.49 -17.34 19.68 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.503 176.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' MET . . . -74.18 -67.86 0.58 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.35 -1.469 . . . . 0.0 107.845 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.628 ' C ' ' CD2' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.03 -18.15 8.76 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.714 ' HA ' HG13 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.68 -64.36 0.88 Allowed 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.825 -1.172 . . . . 0.0 108.427 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.577 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 22.2 pt-20 -62.3 -33.39 74.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.866 -1.146 . . . . 0.0 108.238 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.721 ' O ' HD21 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -57.75 -64.28 0.96 Allowed 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HA ' HD23 ' A' ' 73' ' ' LEU . . . -48.63 -8.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 112.191 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -110.4 -65.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.395 -1.441 . . . . 0.0 110.655 -178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 73' ' ' LEU . 8.6 p -60.38 -11.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -0.777 . . . . 0.0 109.805 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -110.16 -36.81 5.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 110.604 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.669 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 3.7 pttp -66.53 -27.83 68.07 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.486 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -65.45 -33.5 76.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.538 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.536 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 2.7 pt-20 -57.02 -25.93 59.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.449 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.536 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . 120.32 17.29 4.46 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.581 ' CG2' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -102.03 143.08 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 110.826 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.622 ' HB3' ' CD ' ' A' ' 48' ' ' LYS . 3.1 tm-20 -81.93 167.79 18.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 1.4 p -168.68 101.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 122.071 0.939 . . . . 0.0 110.464 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 65.6 m -108.14 -174.05 2.43 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.667 ' CE1' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -123.71 113.23 18.34 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 117.53 -1.668 . . . . 0.0 111.943 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . . . -90.8 90.0 7.73 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.657 HD12 ' CE2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -164.09 139.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.828 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.5 t-80 -48.25 147.1 4.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.582 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 37.7 Cg_endo -65.93 41.78 0.15 Allowed 'Trans proline' 0 C--N 1.293 -2.356 0 O-C-N 122.75 0.868 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.747 HG22 ' H2D' ' A' ' 755' ' ' NAP . 27.9 m -165.65 18.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' A' ' 133' ' ' VAL . . . -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.436 -1.415 . . . . 0.0 110.777 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA2' ' SD ' ' A' ' 95' ' ' MET . . . 148.31 -131.34 3.76 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' O ' ' N7N' ' A' ' 755' ' ' NAP . 2.9 mtp-105 -83.69 -113.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -1.11 . . . . 0.0 109.733 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.438 ' HB2' ' CG ' ' A' ' 94' ' ' HIS . 2.1 mtt -53.66 176.78 0.1 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 110.091 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HA ' HG11 ' A' ' 87' ' ' VAL . 40.7 Cg_endo -76.38 -80.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.233 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.62 57.06 0.94 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.693 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -117.32 -49.26 2.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.372 -1.075 . . . . 0.0 110.009 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.612 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -48.73 -20.86 0.52 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.042 -1.661 . . . . 0.0 109.621 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 94' ' ' HIS . 7.2 m120 -77.6 -15.21 59.36 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 94' ' ' HIS . 16.0 m -67.66 -56.62 12.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.405 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.642 ' H ' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -49.16 -31.92 9.25 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.694 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -75.0 -44.37 48.54 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.635 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.38 -59.87 2.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.72 -0.613 . . . . 0.0 110.712 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -50.07 -32.31 15.28 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 98' ' ' LEU . . . -79.93 -79.28 0.15 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 67' ' ' ARG . 20.3 p-10 -178.21 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.905 -1.122 . . . . 0.0 109.305 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -47.81 155.46 0.81 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 104' ' ' VAL . 30.9 Cg_endo -94.56 162.35 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.709 1.606 . . . . 0.0 112.934 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 30.1 p90 -120.04 3.13 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.353 0.597 . . . . 0.0 110.038 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.74 -31.74 65.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.291 -0.88 . . . . 0.0 109.321 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -99.47 25.34 7.11 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.667 HG11 ' CE1' ' A' ' 82' ' ' TYR 0.304 0.8 OUTLIER -110.22 122.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.36 -176.021 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.549 ' CB ' HD12 ' A' ' 115' ' ' ILE . 11.8 m-85 -111.77 124.9 53.31 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.72 1.248 . . . . 0.0 111.081 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -57.09 -89.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.348 -178.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 113' ' ' GLU . 3.4 tm? -132.05 -79.59 0.51 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.599 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -52.0 -19.53 1.89 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.454 -176.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 110' ' ' PHE . 1.4 pm0 -95.89 0.26 51.8 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.696 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 83' ' ' ALA . 5.2 mm -69.11 -8.69 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 117' ' ' SER . 31.1 p30 -57.87 -15.87 9.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.206 -0.934 . . . . 0.0 109.271 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 92.6 p -98.67 -48.25 5.04 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.479 ' OG ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -47.9 -53.82 14.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.897 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -79.14 -1.29 35.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.657 -0.652 . . . . 0.0 111.447 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.513 ' CG ' HG22 ' A' ' 121' ' ' THR . 3.4 pt20 -75.3 -26.42 58.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.725 -1.234 . . . . 0.0 109.552 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 120' ' ' GLN . 27.2 p -121.8 -24.34 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.92 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . . . -55.29 113.42 1.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.982 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.602 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 6.5 m-20 -83.7 26.81 0.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 0.0 107.795 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.665 ' CG2' ' CG2' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -169.69 -169.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 160' ' ' VAL . . . -172.74 93.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.75 ' CZ ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -73.1 87.63 1.4 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 116.159 -2.217 . . . . 0.0 107.541 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 162' ' ' PHE 0.275 0.5 OUTLIER -80.36 87.16 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -179.493 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.568 HD12 ' CD1' ' A' ' 163' ' ' ILE 0.253 47.5 mm -89.77 110.77 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.039 -174.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.427 ' C ' ' HA2' ' A' ' 54' ' ' GLY . . . 74.19 -10.16 8.38 Favored Glycine 0 N--CA 1.502 3.061 0 O-C-N 121.36 -0.837 . . . . 0.0 113.49 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' N ' ' HA2' ' A' ' 54' ' ' GLY . . . -68.05 168.65 11.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.082 1.941 . . . . 0.0 109.19 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.531 ' OD1' ' CB ' ' A' ' 168' ' ' ALA . 2.7 t30 -156.58 -77.74 0.09 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.535 ' OD2' ' HB2' ' A' ' 171' ' ' TYR . 1.3 p30 -79.29 -14.84 58.75 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.892 -1.13 . . . . 0.0 109.259 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.651 ' HB ' ' O1N' ' A' ' 755' ' ' NAP . 0.8 OUTLIER -70.79 -27.12 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.678 -1.264 . . . . 0.0 109.838 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.566 ' O ' ' HD3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -101.11 -10.19 20.68 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.833 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.553 ' O ' HG22 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -32.2 91.27 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 121.678 -0.639 . . . . 0.0 111.475 -179.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.665 ' HA ' ' CD1' ' A' ' 151' ' ' ILE . 55.7 Cg_endo -69.44 0.48 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.23 1.953 . . . . 0.0 110.658 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 144' ' ' SER . . . -45.61 -42.01 10.77 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.713 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.88 -30.39 70.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.073 0.939 . . . . 0.0 108.487 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 136' ' ' PRO . 9.6 mptt -85.65 -25.11 26.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.42 0.628 . . . . 0.0 110.324 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -104.57 -62.18 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 140' ' ' THR . 2.9 m-20 -154.47 132.39 6.54 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.768 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.95 -8.34 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.964 1.507 . . . . 0.0 110.199 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -50.26 -24.3 2.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.581 ' HA ' ' HG2' ' A' ' 175' ' ' GLU . 84.0 p -39.78 157.35 0.15 Allowed Pre-proline 0 N--CA 1.488 1.442 0 CA-C-O 121.7 0.762 . . . . 0.0 110.822 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.619 ' HG2' ' CG1' ' A' ' 174' ' ' VAL . 38.3 Cg_endo -65.47 -16.84 55.8 Favored 'Trans proline' 0 C--N 1.291 -2.451 0 O-C-N 124.935 2.018 . . . . 0.0 109.709 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.526 HG12 ' N ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -114.9 -159.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.526 ' N ' HG12 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -118.23 -12.2 10.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.552 -1.343 . . . . 0.0 110.626 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 149' ' ' MET . . . 60.1 -168.84 8.06 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.746 ' HB2' ' CD ' ' A' ' 150' ' ' PRO 0.278 0.0 OUTLIER -176.71 -153.23 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.5 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.746 ' CD ' ' HB2' ' A' ' 149' ' ' MET . 29.5 Cg_endo -82.45 72.16 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.665 ' CD1' ' HA ' ' A' ' 136' ' ' PRO . 33.2 pt -55.11 -132.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.866 0.841 . . . . 0.0 110.652 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.754 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -132.33 52.86 2.04 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.573 ' C ' ' O ' ' A' ' 152' ' ' LEU . 2.7 p30 -10.55 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 122.245 1.022 . . . . 0.0 110.262 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.754 ' N ' ' O ' ' A' ' 152' ' ' LEU 0.261 0.7 OUTLIER -81.5 -54.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.226 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.644 ' HB3' ' CG ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -50.45 -24.21 2.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.618 -1.301 . . . . 0.0 108.729 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.09 49.48 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.82 0.819 . . . . 0.0 109.714 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 158' ' ' GLY . . . -148.35 178.69 8.37 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 123' ' ' ASP . . . -57.66 -97.64 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 C-N-CA 116.673 -2.68 . . . . 0.0 108.339 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 21.2 m -96.97 170.37 9.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.413 -1.639 . . . . 0.0 109.878 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.608 ' HB ' ' N ' ' A' ' 185' ' ' MET . 77.9 t -144.23 132.61 18.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.778 . . . . 0.0 109.1 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.701 ' N ' ' CD2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -107.94 88.61 2.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.59 -1.319 . . . . 0.0 111.358 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.688 ' CB ' ' HA ' ' A' ' 186' ' ' MET . 0.1 OUTLIER -83.9 88.39 7.12 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.656 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 2.9 mp -85.65 122.18 38.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.669 -1.269 . . . . 0.0 112.896 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.559 ' CB ' ' NZ ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -178.41 166.59 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 177.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.521 ' NH1' ' O2X' ' A' ' 755' ' ' NAP . 0.3 OUTLIER -54.1 -75.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.8 p -174.26 -70.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.032 -1.043 . . . . 0.0 110.094 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.6 mtm -73.11 58.05 0.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.531 ' CB ' ' OD1' ' A' ' 131' ' ' ASN . . . -69.0 109.33 3.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 170' ' ' GLY . 88.2 p -73.25 -70.37 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 110.56 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.648 ' CA ' ' PA ' ' A' ' 755' ' ' NAP . . . 71.03 -165.2 53.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.535 ' HB2' ' OD2' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -73.43 -11.53 60.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.821 -1.399 . . . . 0.0 110.386 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 146' ' ' ILE . . . -151.38 -62.01 0.18 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.15 -0.969 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.26 20.95 59.07 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.619 ' CG1' ' HG2' ' A' ' 145' ' ' PRO . 7.9 m -85.38 -140.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HG2' ' HA ' ' A' ' 144' ' ' SER . 1.8 mm-40 -36.13 121.79 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.776 0.798 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.613 ' O ' ' CD2' ' A' ' 179' ' ' PHE 0.256 0.0 OUTLIER -165.81 36.42 0.05 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -178.264 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -60.01 -5.56 1.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.979 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.644 ' CG ' ' HB3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -35.57 -29.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.757 -0.589 . . . . 0.0 110.678 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 29.4 p90 -77.69 38.45 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.122 -0.986 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -131.75 -4.0 3.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.689 -1.257 . . . . 0.0 111.161 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -103.1 178.85 4.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.903 -1.123 . . . . 0.0 111.256 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.796 ' O ' ' N ' ' A' ' 184' ' ' THR . 0.0 OUTLIER -22.5 132.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' A' ' 159' ' ' THR . 0.6 OUTLIER -14.15 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.796 ' N ' ' O ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -121.5 118.78 30.17 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.383 -1.448 . . . . 0.0 107.478 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -170.22 -143.15 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 120.827 3.64 . . . . 0.0 120.827 -178.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.688 ' HA ' ' CB ' ' A' ' 162' ' ' PHE 0.259 3.2 ttp -123.11 144.12 49.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.392 1.877 . . . . 0.0 108.42 -176.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.625 ' CD2' ' C ' ' A' ' 186' ' ' MET . 0.3 OUTLIER -122.62 93.47 3.98 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.055 -176.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -35.17 139.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.415 0.626 . . . . 0.0 110.483 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.49 -172.7 20.74 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' LYS . 6.3 m-20 -101.19 141.41 34.11 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 163' ' ' ILE . . . -45.32 -24.68 0.31 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 109.246 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 193' ' ' LYS . 0.0 OUTLIER -69.98 -28.24 65.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.533 ' N ' ' HG3' ' A' ' 192' ' ' LYS . 0.6 OUTLIER -83.28 -16.69 45.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.593 ' O ' ' CG2' ' A' ' 198' ' ' ILE . 15.1 tmm? -62.33 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.756 -0.59 . . . . 0.0 110.261 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.631 ' CG2' ' CG1' ' A' ' 199' ' ' VAL . 1.9 m -66.89 -19.65 65.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.106 -0.996 . . . . 0.0 113.176 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 200' ' ' GLN . 0.7 OUTLIER -65.41 -40.45 93.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.087 -1.633 . . . . 0.0 110.54 -178.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' MET . 0.2 OUTLIER -81.7 -41.3 21.52 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.521 -1.362 . . . . 0.0 111.217 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.593 ' CG2' ' O ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -76.31 -70.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.962 -1.086 . . . . 0.0 112.223 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.631 ' CG1' ' CG2' ' A' ' 195' ' ' THR . 0.4 OUTLIER -84.01 -14.73 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 112.308 -175.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 196' ' ' GLU . 10.1 tm0? -110.96 -13.61 14.08 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.631 -1.293 . . . . 0.0 111.661 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 197' ' ' GLN . . . -173.41 58.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.781 -1.199 . . . . 0.0 112.093 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.57 ' CG ' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -51.72 -77.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.899 -1.126 . . . . 0.0 110.266 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.79 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' NAP . . . . . 0.747 ' H2D' HG22 ' A' ' 87' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.038 0.447 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 1.2 p -137.63 -101.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 111.102 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 31' ' ' VAL 0.253 0.3 OUTLIER -175.23 36.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 117.964 -1.494 . . . . 0.0 111.629 -177.674 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -139.52 -176.3 4.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.954 -1.091 . . . . 0.0 110.285 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' N ' ' HD3' ' A' ' 32' ' ' LYS . . . -156.59 -77.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.47 142.55 28.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -124.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.283 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -52.58 -37.17 57.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 0.0 109.446 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -44.61 -27.6 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 108.727 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 36' ' ' ALA . 14.2 t70 -77.95 -37.13 48.22 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB3' ' HB ' ' A' ' 198' ' ' ILE . . . -48.46 -48.29 37.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.325 -0.86 . . . . 0.0 109.647 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CG ' ' A' ' 202' ' ' MET . . . -38.05 -32.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.73 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.77 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 1.9 m-85 -85.07 -55.34 4.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.286 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.778 HG12 HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -73.49 -12.6 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.258 -0.902 . . . . 0.0 110.332 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 1.01 ' CE ' HD12 ' A' ' 161' ' ' LEU . 2.3 mtt -114.87 -72.69 0.68 Allowed 'General case' 0 C--N 1.284 -2.276 0 O-C-N 121.259 -0.901 . . . . 0.0 111.356 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HD3' ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.26 12.13 3.11 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 41' ' ' PHE . 11.4 t30 -167.23 46.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.897 -1.127 . . . . 0.0 110.62 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 41' ' ' PHE . . . -132.13 90.18 2.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -19.57 -45.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -146.75 115.96 6.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.138 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.143 HG22 ' CG2' ' A' ' 124' ' ' VAL . 1.8 t -135.69 -157.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.431 0 CA-C-O 122.011 0.91 . . . . 0.0 109.355 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.863 HG21 ' OG ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -162.35 103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.661 -0.649 . . . . 0.0 109.878 179.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.825 HD12 ' CD1' ' A' ' 126' ' ' PHE . 1.2 tp -63.27 110.07 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 127' ' ' VAL . 2.0 m -101.58 96.28 6.16 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 117.694 -1.602 . . . . 0.0 109.074 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.623 ' HB3' ' HE3' ' A' ' 57' ' ' MET . 53.6 Cg_endo -66.91 106.88 1.21 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 110.527 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 130' ' ' ALA . . . -96.78 -143.91 15.95 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.904 ' O ' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -77.39 -45.59 25.44 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.309 -1.112 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 60' ' ' ALA . . . -67.07 -62.74 4.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.254 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.916 ' O ' ' HB3' ' A' ' 62' ' ' ALA 0.287 0.8 OUTLIER -10.66 -76.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.759 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.036 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -72.16 -32.34 66.78 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.659 0.742 . . . . 0.0 111.004 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -102.41 24.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 122.426 1.108 . . . . 0.0 108.669 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.074 ' CB ' ' HB3' ' A' ' 191' ' ' ALA . . . -122.21 -41.95 2.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.932 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' HB2' ' CA ' ' A' ' 192' ' ' LYS . 0.2 OUTLIER 155.03 -27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.007 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -46.22 -47.53 17.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -31.98 -56.23 0.3 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -97.49 -17.34 19.68 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.503 176.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -74.18 -67.86 0.58 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.35 -1.469 . . . . 0.0 107.845 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.03 -18.15 8.76 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HB2' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -65.68 -64.36 0.88 Allowed 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.825 -1.172 . . . . 0.0 108.427 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.602 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 22.2 pt-20 -62.3 -33.39 74.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.866 -1.146 . . . . 0.0 108.238 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.822 ' O ' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -57.75 -64.28 0.96 Allowed 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' CA ' HD22 ' A' ' 73' ' ' LEU . . . -48.63 -8.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 112.191 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -110.4 -65.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.395 -1.441 . . . . 0.0 110.655 -178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 68' ' ' GLU . 8.6 p -60.38 -11.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -0.777 . . . . 0.0 109.805 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.149 HD23 ' N ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -110.16 -36.81 5.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 110.604 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 1.149 ' N ' HD23 ' A' ' 73' ' ' LEU . 3.7 pttp -66.53 -27.83 68.07 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -65.45 -33.5 76.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.538 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.544 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 2.7 pt-20 -57.02 -25.93 59.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.449 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . 120.32 17.29 4.46 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 73' ' ' LEU . 7.6 p -102.03 143.08 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 110.826 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB3' ' CD ' ' A' ' 48' ' ' LYS . 3.1 tm-20 -81.93 167.79 18.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 1.4 p -168.68 101.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 122.071 0.939 . . . . 0.0 110.464 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.586 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 65.6 m -108.14 -174.05 2.43 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.984 ' CE1' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -123.71 113.23 18.34 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 117.53 -1.668 . . . . 0.0 111.943 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.984 ' O ' HD13 ' A' ' 152' ' ' LEU . . . -90.8 90.0 7.73 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.056 HG22 HG11 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -164.09 139.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.828 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.5 t-80 -48.25 147.1 4.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 37.7 Cg_endo -65.93 41.78 0.15 Allowed 'Trans proline' 0 C--N 1.293 -2.356 0 O-C-N 122.75 0.868 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' PRO . 27.9 m -165.65 18.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.025 ' HB2' HG21 ' A' ' 133' ' ' VAL . . . -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.436 -1.415 . . . . 0.0 110.777 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA3' ' SD ' ' A' ' 95' ' ' MET . . . 148.31 -131.34 3.76 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' O ' ' N7N' ' A' ' 755' ' ' NAP . 2.9 mtp-105 -83.69 -113.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -1.11 . . . . 0.0 109.733 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.461 ' HB2' ' CG ' ' A' ' 94' ' ' HIS . 2.1 mtt -53.66 176.78 0.1 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 110.091 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 94' ' ' HIS . 40.7 Cg_endo -76.38 -80.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.233 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.62 57.06 0.94 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 1.061 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -117.32 -49.26 2.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.372 -1.075 . . . . 0.0 110.009 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . 1.073 ' HA ' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -48.73 -20.86 0.52 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.042 -1.661 . . . . 0.0 109.621 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 94' ' ' HIS . 7.2 m120 -77.6 -15.21 59.36 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 94' ' ' HIS . 16.0 m -67.66 -56.62 12.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.405 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.073 HD21 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -49.16 -31.92 9.25 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.927 ' HA ' HG13 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -75.0 -44.37 48.54 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.635 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.38 -59.87 2.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.72 -0.613 . . . . 0.0 110.712 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -50.07 -32.31 15.28 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.763 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.93 -79.28 0.15 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 67' ' ' ARG . 20.3 p-10 -178.21 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.905 -1.122 . . . . 0.0 109.305 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -47.81 155.46 0.81 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 104' ' ' VAL . 30.9 Cg_endo -94.56 162.35 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.709 1.606 . . . . 0.0 112.934 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.634 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 30.1 p90 -120.04 3.13 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.353 0.597 . . . . 0.0 110.038 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.74 -31.74 65.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.291 -0.88 . . . . 0.0 109.321 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -99.47 25.34 7.11 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.984 HG13 ' CE1' ' A' ' 82' ' ' TYR 0.304 0.8 OUTLIER -110.22 122.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.36 -176.021 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HD11 ' A' ' 115' ' ' ILE . 11.8 m-85 -111.77 124.9 53.31 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.72 1.248 . . . . 0.0 111.081 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -57.09 -89.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.348 -178.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.818 HD11 ' O ' ' A' ' 150' ' ' PRO . 3.4 tm? -132.05 -79.59 0.51 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.599 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.726 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -52.0 -19.53 1.89 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.454 -176.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 110' ' ' PHE . 1.4 pm0 -95.89 0.26 51.8 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.696 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 110' ' ' PHE . 5.2 mm -69.11 -8.69 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 117' ' ' SER . 31.1 p30 -57.87 -15.87 9.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.206 -0.934 . . . . 0.0 109.271 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 92.6 p -98.67 -48.25 5.04 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.863 ' OG ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -47.9 -53.82 14.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.897 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -79.14 -1.29 35.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.657 -0.652 . . . . 0.0 111.447 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.663 ' CG ' HG23 ' A' ' 121' ' ' THR . 1.9 pt20 -75.3 -26.42 58.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.725 -1.234 . . . . 0.0 109.552 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.663 HG23 ' CG ' ' A' ' 120' ' ' GLN . 27.2 p -121.8 -24.34 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.92 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . . . -55.29 113.42 1.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.982 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 124' ' ' VAL . 6.5 m-20 -83.7 26.81 0.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 0.0 107.795 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.143 ' CG2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -169.69 -169.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.891 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -172.74 93.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.825 ' CD1' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -73.1 87.63 1.4 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 116.159 -2.217 . . . . 0.0 107.541 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 162' ' ' PHE 0.275 0.5 OUTLIER -80.36 87.16 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -179.493 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 163' ' ' ILE 0.253 47.5 mm -89.77 110.77 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.039 -174.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.425 ' C ' ' HA3' ' A' ' 54' ' ' GLY . . . 74.19 -10.16 8.38 Favored Glycine 0 N--CA 1.502 3.061 0 O-C-N 121.36 -0.837 . . . . 0.0 113.49 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . -68.05 168.65 11.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.082 1.941 . . . . 0.0 109.19 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.531 ' OD1' ' CB ' ' A' ' 168' ' ' ALA . 2.7 t30 -156.58 -77.74 0.09 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.613 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 1.3 p30 -79.29 -14.84 58.75 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.892 -1.13 . . . . 0.0 109.259 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.056 HG11 HG22 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -70.79 -27.12 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.678 -1.264 . . . . 0.0 109.838 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.994 HG23 ' CD1' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -101.11 -10.19 20.68 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.833 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 132' ' ' ASP . 5.4 p30 -32.2 91.27 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 121.678 -0.639 . . . . 0.0 111.475 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.939 ' O ' HG23 ' A' ' 140' ' ' THR . 55.7 Cg_endo -69.44 0.48 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.23 1.953 . . . . 0.0 110.658 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 175' ' ' GLU . . . -45.61 -42.01 10.77 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.713 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' HA3' ' A' ' 148' ' ' GLY . . . -61.88 -30.39 70.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.073 0.939 . . . . 0.0 108.487 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 136' ' ' PRO . 9.6 mptt -85.65 -25.11 26.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.42 0.628 . . . . 0.0 110.324 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.939 HG23 ' O ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -104.57 -62.18 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 140' ' ' THR . 2.9 m-20 -154.47 132.39 6.54 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.768 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.95 -8.34 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.964 1.507 . . . . 0.0 110.199 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -50.26 -24.3 2.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.594 ' HB3' ' HB1' ' A' ' 137' ' ' ALA . 84.0 p -39.78 157.35 0.15 Allowed Pre-proline 0 N--CA 1.488 1.442 0 CA-C-O 121.7 0.762 . . . . 0.0 110.822 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.976 ' HG2' HG11 ' A' ' 174' ' ' VAL . 38.3 Cg_endo -65.47 -16.84 55.8 Favored 'Trans proline' 0 C--N 1.291 -2.451 0 O-C-N 124.935 2.018 . . . . 0.0 109.709 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.073 HD12 HG21 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -114.9 -159.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -118.23 -12.2 10.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.552 -1.343 . . . . 0.0 110.626 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 138' ' ' ALA . . . 60.1 -168.84 8.06 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.773 ' HB2' ' CD ' ' A' ' 150' ' ' PRO 0.278 0.0 OUTLIER -176.71 -153.23 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.5 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.818 ' O ' HD11 ' A' ' 112' ' ' LEU . 29.5 Cg_endo -82.45 72.16 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 136' ' ' PRO . 33.2 pt -55.11 -132.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.866 0.841 . . . . 0.0 110.652 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.994 ' CD1' HG23 ' A' ' 134' ' ' THR . 0.0 OUTLIER -132.33 52.86 2.04 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.573 ' C ' ' O ' ' A' ' 152' ' ' LEU . 2.7 p30 -10.55 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 122.245 1.022 . . . . 0.0 110.262 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.754 ' N ' ' O ' ' A' ' 152' ' ' LEU 0.261 0.7 OUTLIER -81.5 -54.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.226 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.662 ' HB3' ' CG ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -50.45 -24.21 2.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.618 -1.301 . . . . 0.0 108.729 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.548 ' CE ' ' HA ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.09 49.48 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.82 0.819 . . . . 0.0 109.714 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 158' ' ' GLY . . . -148.35 178.69 8.37 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 123' ' ' ASP . . . -57.66 -97.64 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 C-N-CA 116.673 -2.68 . . . . 0.0 108.339 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 21.2 m -96.97 170.37 9.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.413 -1.639 . . . . 0.0 109.878 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' A' ' 125' ' ' ALA . 77.9 t -144.23 132.61 18.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.778 . . . . 0.0 109.1 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.01 HD12 ' CE ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -107.94 88.61 2.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.59 -1.319 . . . . 0.0 111.358 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -83.9 88.39 7.12 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 128' ' ' ILE . 2.9 mp -85.65 122.18 38.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.669 -1.269 . . . . 0.0 112.896 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.559 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -178.41 166.59 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 177.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.521 ' NH1' ' O2X' ' A' ' 755' ' ' NAP . 0.3 OUTLIER -54.1 -75.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.8 p -174.26 -70.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.032 -1.043 . . . . 0.0 110.094 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.6 mtm -73.11 58.05 0.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.536 ' HB2' ' O3X' ' A' ' 755' ' ' NAP . . . -69.0 109.33 3.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 170' ' ' GLY . 88.2 p -73.25 -70.37 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 110.56 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.648 ' CA ' ' PA ' ' A' ' 755' ' ' NAP . . . 71.03 -165.2 53.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.56 ' HB2' ' OD2' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -73.43 -11.53 60.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.821 -1.399 . . . . 0.0 110.386 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.38 -62.01 0.18 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.15 -0.969 . . . . 0.0 110.151 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.26 20.95 59.07 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 1.073 HG21 HD12 ' A' ' 146' ' ' ILE . 7.9 m -85.38 -140.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 137' ' ' ALA . 1.8 mm-40 -36.13 121.79 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.776 0.798 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.613 ' O ' ' CD2' ' A' ' 179' ' ' PHE 0.256 0.0 OUTLIER -165.81 36.42 0.05 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -178.264 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -60.01 -5.56 1.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.979 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -35.57 -29.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.757 -0.589 . . . . 0.0 110.678 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.827 ' N ' HD23 ' A' ' 178' ' ' LEU . 29.4 p90 -77.69 38.45 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.122 -0.986 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -131.75 -4.0 3.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.689 -1.257 . . . . 0.0 111.161 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -103.1 178.85 4.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.903 -1.123 . . . . 0.0 111.256 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.796 ' O ' ' N ' ' A' ' 184' ' ' THR . 0.0 OUTLIER -22.5 132.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.66 ' O ' ' HA ' ' A' ' 159' ' ' THR . 0.6 OUTLIER -14.15 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.836 ' OG1' HG23 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -121.5 118.78 30.17 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.383 -1.448 . . . . 0.0 107.478 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -170.22 -143.15 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 120.827 3.64 . . . . 0.0 120.827 -178.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 1.074 ' C ' HD23 ' A' ' 187' ' ' LEU 0.259 3.2 ttp -123.11 144.12 49.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.392 1.877 . . . . 0.0 108.42 -176.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.074 HD23 ' C ' ' A' ' 186' ' ' MET . 0.3 OUTLIER -122.62 93.47 3.98 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.055 -176.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -35.17 139.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.415 0.626 . . . . 0.0 110.483 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.49 -172.7 20.74 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' HG3' ' A' ' 192' ' ' LYS . 6.3 m-20 -101.19 141.41 34.11 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 1.074 ' HB3' ' CB ' ' A' ' 60' ' ' ALA . . . -45.32 -24.68 0.31 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 109.246 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.554 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -69.98 -28.24 65.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 196' ' ' GLU . 0.6 OUTLIER -83.28 -16.69 45.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.865 ' HE2' HD12 ' A' ' 128' ' ' ILE . 15.1 tmm? -62.33 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.756 -0.59 . . . . 0.0 110.261 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 199' ' ' VAL . 1.9 m -66.89 -19.65 65.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.106 -0.996 . . . . 0.0 113.176 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.71 ' HA ' ' HB3' ' A' ' 200' ' ' GLN . 0.7 OUTLIER -65.41 -40.45 93.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.087 -1.633 . . . . 0.0 110.54 -178.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 202' ' ' MET . 0.2 OUTLIER -81.7 -41.3 21.52 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.521 -1.362 . . . . 0.0 111.217 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.781 HD13 ' HB ' ' A' ' 199' ' ' VAL . 0.0 OUTLIER -76.31 -70.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.962 -1.086 . . . . 0.0 112.223 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 195' ' ' THR . 0.4 OUTLIER -84.01 -14.73 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 112.308 -175.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 196' ' ' GLU . 10.1 tm0? -110.96 -13.61 14.08 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.631 -1.293 . . . . 0.0 111.661 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 197' ' ' GLN . . . -173.41 58.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.781 -1.199 . . . . 0.0 112.093 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.573 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -51.72 -77.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.899 -1.126 . . . . 0.0 110.266 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.79 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 755' ' ' NAP . . . . . 0.671 H52A ' CD2' ' A' ' 55' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.038 0.447 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' CE1' ' A' ' 180' ' ' PHE . 1.2 p -137.63 -101.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.0 111.102 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.755 ' O ' HG13 ' A' ' 31' ' ' VAL 0.253 0.3 OUTLIER -175.23 36.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 117.964 -1.494 . . . . 0.0 111.629 -177.674 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -139.52 -176.3 4.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.954 -1.091 . . . . 0.0 110.285 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' N ' ' HD3' ' A' ' 32' ' ' LYS . . . -156.59 -77.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.47 142.55 28.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -124.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.283 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -52.58 -37.17 57.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 0.0 109.446 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -44.61 -27.6 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 108.727 178.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 36' ' ' ALA . 14.2 t70 -77.95 -37.13 48.22 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB3' ' HB ' ' A' ' 198' ' ' ILE . . . -48.46 -48.29 37.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.325 -0.86 . . . . 0.0 109.647 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CG ' ' A' ' 202' ' ' MET . . . -38.05 -32.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.823 . . . . 0.0 110.73 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.77 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 1.9 m-85 -85.07 -55.34 4.1 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.286 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.778 HG12 HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -73.49 -12.6 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.258 -0.902 . . . . 0.0 110.332 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 1.01 ' CE ' HD12 ' A' ' 161' ' ' LEU . 2.3 mtt -114.87 -72.69 0.68 Allowed 'General case' 0 C--N 1.284 -2.276 0 O-C-N 121.259 -0.901 . . . . 0.0 111.356 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HD3' ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.26 12.13 3.11 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -177.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 41' ' ' PHE . 11.4 t30 -167.23 46.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.897 -1.127 . . . . 0.0 110.62 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 41' ' ' PHE . . . -132.13 90.18 2.78 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -19.57 -45.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.723 ' HB3' ' HA ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -146.75 115.96 6.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.138 -176.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.143 HG22 ' CG2' ' A' ' 124' ' ' VAL . 1.8 t -135.69 -157.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.431 0 CA-C-O 122.011 0.91 . . . . 0.0 109.355 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.863 HG21 ' OG ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -162.35 103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.661 -0.649 . . . . 0.0 109.878 179.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.825 HD12 ' CD1' ' A' ' 126' ' ' PHE . 1.2 tp -63.27 110.07 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 127' ' ' VAL . 2.0 m -101.58 96.28 6.16 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 117.694 -1.602 . . . . 0.0 109.074 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.623 ' HB3' ' HE3' ' A' ' 57' ' ' MET . 53.6 Cg_endo -66.91 106.88 1.21 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 O-C-N 123.802 1.422 . . . . 0.0 110.527 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 130' ' ' ALA . . . -96.78 -143.91 15.95 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.904 ' O ' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -77.39 -45.59 25.44 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.309 -1.112 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 60' ' ' ALA . . . -67.07 -62.74 4.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.254 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.916 ' O ' ' HB3' ' A' ' 62' ' ' ALA 0.287 0.8 OUTLIER -10.66 -76.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.759 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.036 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -72.16 -32.34 66.78 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.659 0.742 . . . . 0.0 111.004 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -102.41 24.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 122.426 1.108 . . . . 0.0 108.669 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.074 ' CB ' ' HB3' ' A' ' 191' ' ' ALA . . . -122.21 -41.95 2.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.932 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' HB2' ' CA ' ' A' ' 192' ' ' LYS . 0.2 OUTLIER 155.03 -27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.007 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -46.22 -47.53 17.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -31.98 -56.23 0.3 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -97.49 -17.34 19.68 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.503 176.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -74.18 -67.86 0.58 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.35 -1.469 . . . . 0.0 107.845 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.03 -18.15 8.76 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HB2' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -65.68 -64.36 0.88 Allowed 'General case' 0 C--N 1.309 -1.165 0 O-C-N 120.825 -1.172 . . . . 0.0 108.427 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.602 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 22.2 pt-20 -62.3 -33.39 74.56 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.866 -1.146 . . . . 0.0 108.238 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.822 ' O ' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -57.75 -64.28 0.96 Allowed 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' CA ' HD22 ' A' ' 73' ' ' LEU . . . -48.63 -8.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 112.191 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -110.4 -65.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.395 -1.441 . . . . 0.0 110.655 -178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 68' ' ' GLU . 8.6 p -60.38 -11.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -0.777 . . . . 0.0 109.805 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.149 HD23 ' N ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -110.16 -36.81 5.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 110.604 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 1.149 ' N ' HD23 ' A' ' 73' ' ' LEU . 3.7 pttp -66.53 -27.83 68.07 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -65.45 -33.5 76.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.538 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.544 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 2.7 pt-20 -57.02 -25.93 59.39 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.449 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . 120.32 17.29 4.46 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 73' ' ' LEU . 7.6 p -102.03 143.08 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 110.826 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB3' ' CD ' ' A' ' 48' ' ' LYS . 3.1 tm-20 -81.93 167.79 18.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 1.4 p -168.68 101.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 122.071 0.939 . . . . 0.0 110.464 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.586 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 65.6 m -108.14 -174.05 2.43 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.984 ' CE1' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -123.71 113.23 18.34 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 117.53 -1.668 . . . . 0.0 111.943 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.984 ' O ' HD13 ' A' ' 152' ' ' LEU . . . -90.8 90.0 7.73 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.221 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.056 HG22 HG11 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -164.09 139.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 117.193 -1.803 . . . . 0.0 111.828 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.5 t-80 -48.25 147.1 4.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 37.7 Cg_endo -65.93 41.78 0.15 Allowed 'Trans proline' 0 C--N 1.293 -2.356 0 O-C-N 122.75 0.868 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' PRO . 27.9 m -165.65 18.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.025 ' HB2' HG21 ' A' ' 133' ' ' VAL . . . -69.54 82.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.436 -1.415 . . . . 0.0 110.777 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA3' ' SD ' ' A' ' 95' ' ' MET . . . 148.31 -131.34 3.76 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' O ' ' N7N' ' A' ' 755' ' ' NAP . 2.9 mtp-105 -83.69 -113.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -1.11 . . . . 0.0 109.733 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.461 ' HB2' ' CG ' ' A' ' 94' ' ' HIS . 2.1 mtt -53.66 176.78 0.1 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.796 -1.19 . . . . 0.0 110.091 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 94' ' ' HIS . 40.7 Cg_endo -76.38 -80.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.233 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.62 57.06 0.94 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 1.061 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -117.32 -49.26 2.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.372 -1.075 . . . . 0.0 110.009 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 1.073 ' HA ' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -48.73 -20.86 0.52 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.042 -1.661 . . . . 0.0 109.621 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 94' ' ' HIS . 7.2 m120 -77.6 -15.21 59.36 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 94' ' ' HIS . 16.0 m -67.66 -56.62 12.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.405 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.073 HD21 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -49.16 -31.92 9.25 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.927 ' HA ' HG13 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -75.0 -44.37 48.54 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.635 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.38 -59.87 2.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.72 -0.613 . . . . 0.0 110.712 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -50.07 -32.31 15.28 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 -179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.763 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.93 -79.28 0.15 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' OD1' ' CB ' ' A' ' 67' ' ' ARG . 20.3 p-10 -178.21 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.905 -1.122 . . . . 0.0 109.305 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -47.81 155.46 0.81 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' HG23 ' A' ' 104' ' ' VAL . 30.9 Cg_endo -94.56 162.35 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.709 1.606 . . . . 0.0 112.934 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.634 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 30.1 p90 -120.04 3.13 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.353 0.597 . . . . 0.0 110.038 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.74 -31.74 65.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.291 -0.88 . . . . 0.0 109.321 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -99.47 25.34 7.11 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.984 HG13 ' CE1' ' A' ' 82' ' ' TYR 0.304 0.8 OUTLIER -110.22 122.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.36 -176.021 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HD11 ' A' ' 115' ' ' ILE . 11.8 m-85 -111.77 124.9 53.31 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.72 1.248 . . . . 0.0 111.081 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -57.09 -89.8 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.348 -178.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.818 HD11 ' O ' ' A' ' 150' ' ' PRO . 3.4 tm? -132.05 -79.59 0.51 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.599 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.726 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -52.0 -19.53 1.89 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.454 -176.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 110' ' ' PHE . 1.4 pm0 -95.89 0.26 51.8 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.696 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 110' ' ' PHE . 5.2 mm -69.11 -8.69 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 117' ' ' SER . 31.1 p30 -57.87 -15.87 9.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.206 -0.934 . . . . 0.0 109.271 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 92.6 p -98.67 -48.25 5.04 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.512 -0.743 . . . . 0.0 110.118 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.863 ' OG ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -47.9 -53.82 14.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.897 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -79.14 -1.29 35.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.657 -0.652 . . . . 0.0 111.447 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.663 ' CG ' HG23 ' A' ' 121' ' ' THR . 3.4 pt20 -75.3 -26.42 58.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.725 -1.234 . . . . 0.0 109.552 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.663 HG23 ' CG ' ' A' ' 120' ' ' GLN . 27.2 p -121.8 -24.34 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.92 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . . . -55.29 113.42 1.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.982 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 124' ' ' VAL . 6.5 m-20 -83.7 26.81 0.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 0.0 107.795 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.143 ' CG2' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -169.69 -169.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.891 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -172.74 93.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.825 ' CD1' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -73.1 87.63 1.4 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 116.159 -2.217 . . . . 0.0 107.541 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 162' ' ' PHE 0.275 0.5 OUTLIER -80.36 87.16 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -179.493 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 163' ' ' ILE 0.253 47.5 mm -89.77 110.77 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.039 -174.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.425 ' C ' ' HA3' ' A' ' 54' ' ' GLY . . . 74.19 -10.16 8.38 Favored Glycine 0 N--CA 1.502 3.061 0 O-C-N 121.36 -0.837 . . . . 0.0 113.49 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . -68.05 168.65 11.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.082 1.941 . . . . 0.0 109.19 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.531 ' OD1' ' CB ' ' A' ' 168' ' ' ALA . 2.7 t30 -156.58 -77.74 0.09 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 171' ' ' TYR . 1.3 p30 -79.29 -14.84 58.75 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.892 -1.13 . . . . 0.0 109.259 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.056 HG11 HG22 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -70.79 -27.12 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.678 -1.264 . . . . 0.0 109.838 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.994 HG23 ' CD1' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -101.11 -10.19 20.68 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.833 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.572 ' O ' HG21 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -32.2 91.27 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 121.678 -0.639 . . . . 0.0 111.475 -179.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.939 ' O ' HG23 ' A' ' 140' ' ' THR . 55.7 Cg_endo -69.44 0.48 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.23 1.953 . . . . 0.0 110.658 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 175' ' ' GLU . . . -45.61 -42.01 10.77 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.713 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB2' ' HA3' ' A' ' 148' ' ' GLY . . . -61.88 -30.39 70.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.073 0.939 . . . . 0.0 108.487 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 136' ' ' PRO . 9.6 mptt -85.65 -25.11 26.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.42 0.628 . . . . 0.0 110.324 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.939 HG23 ' O ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -104.57 -62.18 1.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 140' ' ' THR . 2.9 m-20 -154.47 132.39 6.54 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.0 109.768 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.95 -8.34 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.964 1.507 . . . . 0.0 110.199 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -50.26 -24.3 2.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.594 ' HB3' ' HB1' ' A' ' 137' ' ' ALA . 84.0 p -39.78 157.35 0.15 Allowed Pre-proline 0 N--CA 1.488 1.442 0 CA-C-O 121.7 0.762 . . . . 0.0 110.822 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.976 ' HG2' HG11 ' A' ' 174' ' ' VAL . 38.3 Cg_endo -65.47 -16.84 55.8 Favored 'Trans proline' 0 C--N 1.291 -2.451 0 O-C-N 124.935 2.018 . . . . 0.0 109.709 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.073 HD12 HG21 ' A' ' 174' ' ' VAL . 0.2 OUTLIER -114.9 -159.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -118.23 -12.2 10.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.552 -1.343 . . . . 0.0 110.626 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 138' ' ' ALA . . . 60.1 -168.84 8.06 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.773 ' HB2' ' CD ' ' A' ' 150' ' ' PRO 0.278 0.0 OUTLIER -176.71 -153.23 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.5 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.818 ' O ' HD11 ' A' ' 112' ' ' LEU . 29.5 Cg_endo -82.45 72.16 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 136' ' ' PRO . 33.2 pt -55.11 -132.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.866 0.841 . . . . 0.0 110.652 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.994 ' CD1' HG23 ' A' ' 134' ' ' THR . 0.0 OUTLIER -132.33 52.86 2.04 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.573 ' C ' ' O ' ' A' ' 152' ' ' LEU . 2.7 p30 -10.55 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 122.245 1.022 . . . . 0.0 110.262 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.754 ' N ' ' O ' ' A' ' 152' ' ' LEU 0.261 0.7 OUTLIER -81.5 -54.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.226 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.662 ' HB3' ' CG ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -50.45 -24.21 2.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.618 -1.301 . . . . 0.0 108.729 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.548 ' CE ' ' HA ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.09 49.48 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.82 0.819 . . . . 0.0 109.714 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 158' ' ' GLY . . . -148.35 178.69 8.37 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 123' ' ' ASP . . . -57.66 -97.64 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 C-N-CA 116.673 -2.68 . . . . 0.0 108.339 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 183' ' ' ASN . 21.2 m -96.97 170.37 9.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.413 -1.639 . . . . 0.0 109.878 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' A' ' 125' ' ' ALA . 77.9 t -144.23 132.61 18.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.778 . . . . 0.0 109.1 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.01 HD12 ' CE ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -107.94 88.61 2.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.59 -1.319 . . . . 0.0 111.358 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -83.9 88.39 7.12 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 128' ' ' ILE . 2.9 mp -85.65 122.18 38.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.669 -1.269 . . . . 0.0 112.896 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.559 ' NZ ' ' CB ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -178.41 166.59 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 177.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.521 ' NH1' ' O2X' ' A' ' 755' ' ' NAP . 0.3 OUTLIER -54.1 -75.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.8 p -174.26 -70.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.032 -1.043 . . . . 0.0 110.094 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.6 mtm -73.11 58.05 0.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.536 ' HB2' ' O3X' ' A' ' 755' ' ' NAP . . . -69.0 109.33 3.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 170' ' ' GLY . 88.2 p -73.25 -70.37 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 110.56 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.648 ' CA ' ' PA ' ' A' ' 755' ' ' NAP . . . 71.03 -165.2 53.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.56 ' HB2' ' OD2' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -73.43 -11.53 60.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.821 -1.399 . . . . 0.0 110.386 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.38 -62.01 0.18 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.15 -0.969 . . . . 0.0 110.151 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.26 20.95 59.07 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 1.073 HG21 HD12 ' A' ' 146' ' ' ILE . 7.9 m -85.38 -140.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 137' ' ' ALA . 1.8 mm-40 -36.13 121.79 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.776 0.798 . . . . 0.0 111.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.613 ' O ' ' CD2' ' A' ' 179' ' ' PHE 0.256 0.0 OUTLIER -165.81 36.42 0.05 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -178.264 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 179' ' ' PHE . 0.5 OUTLIER -60.01 -5.56 1.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.979 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -35.57 -29.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.757 -0.589 . . . . 0.0 110.678 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.827 ' N ' HD23 ' A' ' 178' ' ' LEU . 29.4 p90 -77.69 38.45 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.122 -0.986 . . . . 0.0 111.493 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -131.75 -4.0 3.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.689 -1.257 . . . . 0.0 111.161 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -103.1 178.85 4.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.903 -1.123 . . . . 0.0 111.256 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.796 ' O ' ' N ' ' A' ' 184' ' ' THR . 0.0 OUTLIER -22.5 132.88 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.661 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.66 ' O ' ' HA ' ' A' ' 159' ' ' THR . 0.6 OUTLIER -14.15 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.836 ' OG1' HG23 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -121.5 118.78 30.17 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.383 -1.448 . . . . 0.0 107.478 178.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.655 ' O ' ' N ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -170.22 -143.15 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 120.827 3.64 . . . . 0.0 120.827 -178.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 1.074 ' C ' HD23 ' A' ' 187' ' ' LEU 0.259 3.2 ttp -123.11 144.12 49.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.392 1.877 . . . . 0.0 108.42 -176.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.074 HD23 ' C ' ' A' ' 186' ' ' MET . 0.3 OUTLIER -122.62 93.47 3.98 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.055 -176.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -35.17 139.49 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.415 0.626 . . . . 0.0 110.483 -178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.49 -172.7 20.74 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' HG3' ' A' ' 192' ' ' LYS . 6.3 m-20 -101.19 141.41 34.11 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 1.074 ' HB3' ' CB ' ' A' ' 60' ' ' ALA . . . -45.32 -24.68 0.31 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 109.246 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.554 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -69.98 -28.24 65.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.447 -0.783 . . . . 0.0 109.589 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 196' ' ' GLU . 0.6 OUTLIER -83.28 -16.69 45.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.865 ' HE2' HD12 ' A' ' 128' ' ' ILE . 15.1 tmm? -62.33 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.756 -0.59 . . . . 0.0 110.261 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 199' ' ' VAL . 1.9 m -66.89 -19.65 65.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.106 -0.996 . . . . 0.0 113.176 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.71 ' HA ' ' HB3' ' A' ' 200' ' ' GLN . 0.7 OUTLIER -65.41 -40.45 93.38 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.087 -1.633 . . . . 0.0 110.54 -178.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 202' ' ' MET . 0.2 OUTLIER -81.7 -41.3 21.52 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.521 -1.362 . . . . 0.0 111.217 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.781 HD13 ' HB ' ' A' ' 199' ' ' VAL . 0.0 OUTLIER -76.31 -70.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.962 -1.086 . . . . 0.0 112.223 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 195' ' ' THR . 0.4 OUTLIER -84.01 -14.73 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 112.308 -175.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.71 ' HB3' ' HA ' ' A' ' 196' ' ' GLU . 10.1 tm0? -110.96 -13.61 14.08 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.631 -1.293 . . . . 0.0 111.661 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 197' ' ' GLN . . . -173.41 58.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.781 -1.199 . . . . 0.0 112.093 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.573 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -51.72 -77.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.899 -1.126 . . . . 0.0 110.266 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.79 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' NAP . . . . . 0.671 H52A ' CD2' ' A' ' 55' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_